Please log in for more information
OncoKDM Lite interprets tumor-based NGS data to guide oncologists in their treatment decision making, providing them with individualized treatment options and clinical trials recommendations for their patients.
It processes, analyses, biologically and clinically interprets VCF data to provide laboratories with a comprehensive report that can then be shared with oncologists, clinicians or healthcare professionals who are responsible for treatment choice. The report contains among others a list of drugs based on the identified DNA/RNA mutations that are classified by therapeutical impact as well as a list of recruiting clinical trials worldwide in which the patient might be eligible for enrollment.
More information
